NeoGenomics, Inc. (NEO) Key Metrics
NEO valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.14B
- Enterprise value
- $2.66B
- P/E (TTM)
- —
- Forward P/E
- 222.2
- PEG ratio
- 2.09
- Price / sales
- 2.8
- Price / book
- 3.0
- EV / EBITDA
- 197.3
- Dividend yield
- —
- Beta
- 1.78
NEO key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsNEO returns How much profit the business earns on the capital it uses.
Return on equity−3.9 pts
−12.4%
2025 · hover or tap a bar for each year
20162025
Return on invested capital+1.8 pts
−4.6%
2025 · hover or tap a bar for each year
20162025
Return on assets−2.5 pts
−7.2%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin+2.2 pts
−3.0%
2025 · hover or tap a bar for each year
20162025
Asset turnover+21.9%
0.49
2025 · hover or tap a bar for each year
20162025
NEO financial health Debt, liquidity and how easily interest is covered.
Debt / equity−15.8%
0.56
2025 · hover or tap a bar for each year
20162025
Net debt+$94.2M
$312.7M
2025 · hover or tap a bar for each year
20162025
Current ratio+115.4%
4.26
2025 · hover or tap a bar for each year
20162025
Interest coverage
-17.6
2025 · hover or tap a bar for each year
20162025
Debt / assets−6.0%
0.35
2025 · hover or tap a bar for each year
20162025
NEO efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding0 days
78 days
2025 · hover or tap a bar for each year
20162025
Days of inventory−2 days
23 days
2025 · hover or tap a bar for each year
20162025
Days payables outstanding−2 days
18 days
2025 · hover or tap a bar for each year
20162025
Cash conversion cycle0 days
82 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue−2.5 pts
3.7%
2025 · hover or tap a bar for each year
20162025
NEO valuation history
Fiscal year-endToday10-year median
NEO returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
NEO debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
NEO cash returned to shareholders
DividendsBuybacksFree cash flow
NEO price vs earnings per share
Share price at year-endEPS (right axis)
NEO key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | — | — | — | — | — | — | — | — | — | $664.5M |
| Enterprise value | — | — | — | — | — | — | — | — | — | $779.9M |
| Price / sales | — | — | — | — | — | — | — | — | — | 2.7 |
| Price / book | — | — | — | — | — | — | — | — | — | 3.6 |
| Price / free cash flow | — | — | — | — | — | — | — | — | — | 47.7 |
| Price / operating cash flow | — | — | — | — | — | — | — | — | — | 30.9 |
| EV / sales | — | — | — | — | — | — | — | — | — | 3.2 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | 30.7 |
| EV / free cash flow | — | — | — | — | — | — | — | — | — | 55.9 |
| Earnings yield | — | — | — | — | — | — | — | — | — | −0.9% |
| Free cash flow yield | — | — | — | — | — | — | — | — | — | 2.1% |
| Dividend yield | — | — | — | — | — | — | — | — | — | 13.2% |
| Shareholder yield (dividends + buybacks) | — | — | — | — | — | — | — | — | — | 21.5% |
| Share price at fiscal year-end | $11.76 | $16.48 | $16.18 | $9.24 | $34.12 | $53.84 | $29.25 | $12.61 | $8.86 | $8.57 |
| Per share | ||||||||||
| Revenue per share | — | — | — | — | — | — | — | — | — | $3.15 |
| Earnings per share | — | — | — | — | — | — | — | — | — | −$0.08 |
| Operating cash flow per share | — | — | — | — | — | — | — | — | — | $0.28 |
| Free cash flow per share | — | — | — | — | — | — | — | — | — | $0.18 |
| Cash per share | — | — | — | — | — | — | — | — | — | $0.16 |
| Book value per share | — | — | — | — | — | — | — | — | — | $2.41 |
| Tangible book value per share | — | — | — | — | — | — | — | — | — | −$0.48 |
| Dividends per share | — | — | — | — | — | — | — | — | — | $1.13 |
| Capex per share | — | — | — | — | — | — | — | — | — | $0.10 |
| Debt per share | — | — | — | — | — | — | — | — | — | $1.65 |
| Shares outstanding | — | — | — | — | — | — | — | — | — | 77.5M |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −12.4% | −8.5% | −9.1% | −13.7% | −0.9% | 0.7% | 1.9% | 1.0% | −0.2% | −2.9% |
| Return on invested capital (ROIC) | −4.6% | −6.4% | −7.4% | −10.5% | −10.3% | −2.0% | 2.9% | 1.9% | 0.8% | 0.7% |
| Return on assets (ROA) | −7.2% | −4.7% | −5.1% | −8.0% | −0.6% | 0.5% | 1.3% | 0.6% | −0.1% | −1.7% |
| Return on tangible assets | −19.7% | −10.2% | −11.2% | −17.8% | −0.9% | 0.6% | 2.1% | 1.6% | −0.3% | −5.4% |
| Free cash flow margin | −3.0% | −5.2% | −5.2% | −19.0% | −18.8% | −6.2% | 0.8% | 11.0% | 1.8% | 5.7% |
| Income quality (OCF / net income) | — | — | — | — | — | 0.35 | 2.92 | 16.96 | — | — |
| Financial health | ||||||||||
| Total debt | $472.3M | $605.3M | $611.7M | $610.9M | $612.8M | $218.2M | $132.9M | $112.3M | $105.4M | $127.9M |
| Cash & short-term investments | $159.6M | $386.8M | $415.2M | $438.0M | $515.4M | $296.3M | $173.0M | $9.8M | $12.8M | $12.5M |
| Net debt | $312.7M | $218.5M | $196.5M | $172.9M | $97.4M | −$78.0M | −$40.1M | $102.5M | $92.6M | $115.3M |
| Debt / equity | 0.56 | 0.67 | 0.65 | 0.61 | 0.55 | 0.31 | 0.26 | 0.35 | 0.51 | 0.69 |
| Debt / assets | 0.35 | 0.37 | 0.36 | 0.35 | 0.33 | 0.22 | 0.19 | 0.22 | 0.31 | 0.38 |
| Net debt / EBITDA | — | — | — | — | 2.09 | −2.72 | −1.07 | 3.22 | 3.49 | 4.55 |
| Current ratio | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 | 6.13 | 4.55 | 1.70 | 2.42 | 1.32 |
| Quick ratio | 3.94 | 1.89 | 5.95 | 6.46 | 7.54 | 5.73 | 4.32 | 1.56 | 2.21 | 1.21 |
| Interest coverage | -17.6 | -13.9 | -15.6 | -20.8 | -14.4 | -2.0 | 3.5 | 1.6 | 0.5 | 0.3 |
| Working capital | $288.0M | $294.8M | $500.5M | $515.4M | $594.3M | $375.5M | $226.8M | $42.7M | $49.9M | $18.9M |
| Invested capital | $1.15B | $1.12B | $1.14B | $1.17B | $1.21B | $616.3M | $467.3M | $422.9M | $298.1M | $301.9M |
| Tangible asset value | $25.7M | $39.9M | $45.6M | $67.0M | $138.8M | $362.6M | $182.2M | −$17.5M | −$15.7M | −$37.5M |
| Net current asset value | −$147.0M | −$139.7M | −$142.9M | −$136.7M | −$80.0M | $154.7M | $88.6M | −$80.9M | −$52.8M | −$71.7M |
| Graham net-net per share | — | — | — | — | — | — | — | — | — | −$1.20 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | $9.6M | $0 | $87.9M |
| Share buybacks (net) | — | — | — | $0 | $0 | $0 | $0 | $50.1M | $0 | $55.0M |
| Dividend payout ratio | — | — | — | — | — | — | — | 363.6% | — | — |
| Dividends + buybacks / free cash flow | — | — | — | — | — | — | 0.0% | 195.9% | 0.0% | — |
| Capex / revenue | 3.7% | 6.2% | 4.9% | 6.1% | 13.2% | 6.5% | 4.9% | 5.2% | 5.7% | 3.1% |
| Capex / operating cash flow | 516.4% | 584.7% | — | — | — | 1,992.9% | 85.7% | 32.0% | 75.9% | 35.1% |
| Capex / depreciation | 0.40 | 0.57 | 0.40 | 0.44 | 1.20 | 0.81 | 0.66 | 0.66 | 0.61 | 0.32 |
| Stock-based compensation / revenue | 5.7% | 5.1% | 4.2% | 4.8% | 4.6% | 2.3% | 2.4% | 2.5% | 2.7% | 2.2% |
| R&D / revenue | 5.1% | 4.7% | 4.6% | 5.9% | 4.5% | 1.9% | 2.1% | 1.1% | 1.5% | 1.9% |
| SG&A / revenue | 37.6% | 47.0% | 47.3% | 54.5% | 58.6% | 43.1% | 42.9% | 41.3% | 36.9% | 36.0% |
| Efficiency | ||||||||||
| Days sales outstanding | 77.7 | 77.9 | 77.4 | 83.0 | 82.5 | 83.0 | 76.9 | 90.6 | 88.1 | 78.1 |
| Days of inventory on hand | 22.7 | 25.1 | 25.5 | 27.0 | 32.5 | 31.0 | 19.8 | 19.7 | 18.1 | 15.5 |
| Days payables outstanding | 18.3 | 20.7 | 21.5 | 21.8 | 26.3 | 31.4 | 32.2 | 34.5 | 52.6 | 57.1 |
| Cash conversion cycle (days) | 82.1 | 82.3 | 81.4 | 88.2 | 88.7 | 82.6 | 64.5 | 75.8 | 53.6 | 36.5 |
| Receivables turnover | 4.70 | 4.69 | 4.71 | 4.40 | 4.42 | 4.40 | 4.75 | 4.03 | 4.14 | 4.67 |
| Payables turnover | 19.90 | 17.67 | 16.99 | 16.75 | 13.86 | 11.61 | 11.35 | 10.59 | 6.94 | 6.39 |
| Inventory turnover | 16.08 | 14.56 | 14.33 | 13.50 | 11.23 | 11.77 | 18.39 | 18.54 | 20.15 | 23.54 |
| Asset turnover | 0.49 | 0.40 | 0.35 | 0.28 | 0.34 | 0.52 | 0.67 | 0.65 | 0.71 | 0.69 |
| Average receivables | $154.9M | $140.9M | $125.5M | $115.9M | $109.5M | $101.0M | $86.1M | $68.7M | $58.0M | $52.2M |
| Average payables | $22.3M | $21.0M | $20.4M | $19.2M | $21.4M | $22.3M | $18.7M | $14.1M | $19.9M | $20.9M |
| Average inventory | $27.7M | $25.5M | $24.2M | $23.8M | $26.5M | $22.0M | $11.5M | $8.1M | $6.9M | $5.7M |
| Intangibles / total assets | 59.6% | 52.7% | 53.3% | 53.5% | 51.8% | 33.6% | 45.8% | 66.9% | 64.4% | 66.5% |
Computed from NEO's annual financial statements (latest annual report filed February 17, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
NEO valuation and financial ratios
NeoGenomics earned a return on equity of −12.4% and a return on invested capital of −4.6% in fiscal 2025. It ended the year with $472.3 million of debt and $159.6 million in cash and short-term investments, net debt of $312.7 million.
See the NEO income statement, the NEO chart for price history, or the NEO stock overview for the latest quote and news.
NEO key metrics FAQ
What is NeoGenomics's return on equity?
NeoGenomics's return on equity (ROE) was −12.4% in fiscal 2025: net income of -$108.0 million on average shareholders' equity of $869.5 million.
What is NeoGenomics's ROIC?
NeoGenomics's return on invested capital was −4.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does NeoGenomics have?
NeoGenomics had total debt of $472.3 million at the end of fiscal 2025, a debt-to-equity ratio of 0.56.
What is NeoGenomics's current ratio?
NeoGenomics's current ratio was 4.26 at the end of fiscal 2025: current assets were 4.26 times current liabilities.